Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC
EGFR Activating MutationNSCLC Stage IIIBNSCLC Stage IV+1 more
StudydirectorStart date: 2020-09-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04768491StudyDirector

Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC

EGFR Activating MutationNSCLC Stage IIIBNSCLC Stage IV+1 more
Unknown

All 1 trials loaded